Vizimpro is a brand name for the drug Dacomitinib. It is a prescription drug used in the treatment of non-small cell lung cancer (NSCLC) characterized by mutations of epidermal growth factor receptor (EGFR). Vizimpro comes in the form of tablets and is meant for oral administration.
Uses
Vizimpro is used to treat non-small cell lung cancer in patients that are:
- EGFR positive
- Previously treated with another EGFR inhibitor and have developed resistance to it
Dacomitinib works by inhibiting the activity of the EGFR tyrosine kinase, which is a protein responsible for the growth of cancer cells. By inhibiting the activity of this protein, the drug slows down or stops the growth and spread of NSCLC.
Benefits
Vizimpro has been shown to be effective in the treatment of NSCLC. Studies have shown that the drug has a longer progression-free survival rate compared to other drugs that are used to treat the same condition. The drug has also been shown to reduce the risk of death and slow down the progression of the disease.
Side Effects
Like most prescription drugs, Vizimpro has some side effects. Some of the common side effects of Vizimpro are:
- Diarrhea
- Rash
- Mouth sores
- Paronychia (infection around nails)
- Decreased appetite
- Nausea/vomiting
Other side effects that are less common include:
- Interstitial lung disease
- Hepatotoxicity
- Cutaneous reactions
- Chronic diarrhea
Patients who experience any of these side effects should contact their healthcare provider.
Warnings
Patients with the following medical history or conditions should not take Vizimpro:
- Severe renal impairment
- Severe hepatic impairment
- Interstitial lung disease
- Concurrent use of sensitive CYP3A substrates with a narrow therapeutic index.
Vizimpro can also interact with other drugs, causing unwanted side effects or reducing the effectiveness of the medication. Patients should inform their healthcare provider of all the drugs they are taking before using Vizimpro.
FAQs
- Q: Can I drive while taking Vizimpro?
A: Vizimpro may cause dizziness or fatigue, and it is recommended that patients do not drive or operate heavy machinery until they know how the drug affects them.
- Q: Can I drink alcohol while taking Vizimpro?
A: Drinking alcohol while taking Vizimpro can increase the risk of liver toxicity. Patients should avoid drinking alcohol while taking the medication.
- Q: Can I take Vizimpro during pregnancy or breastfeeding?
A: Vizimpro is not recommended during pregnancy or breastfeeding. Patients should inform their healthcare provider if they are pregnant or breastfeeding before using the medication.
- Q: How long should I take Vizimpro?
A: Patients should continue taking Vizimpro as long as their healthcare provider has prescribed, even if they start feeling better.
- Q: Can Vizimpro cure my cancer?
A: Vizimpro is not a cure for cancer but can help slow down the progression of the disease and improve the quality of life of patients.
conclusion
In conclusion, Vizimpro is a drug used in the treatment of non-small cell lung cancer characterized by mutations of epidermal growth factor receptor (EGFR). It has proven to be effective in the treatment of NSCLC and has longer progression-free survival compared to other drugs used to treat the same condition. However, like most prescription drugs, Vizimpro has side effects, and patients should inform their healthcare provider of any adverse reactions. Patients should also adhere to the recommended dosage and continue taking the drug as long as prescribed by their healthcare provider.
